What's breaking now, across thousands of outlets.
(RTTNews) - Lupin Limited (500257) announced that it has received U.S. Food and Drug Administration approval for its Abbreviated New Drug Application for Modafinil Tablets USP, 100 mg and 200 mg.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
The US has confirmed 3,134 measles cases so far this year, driven by a growing outbreak in Pennsylvania linked to two deaths that started a feud between the governor and the nation’s top health…
A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the firm.
The prolonged nationwide crisis has crippled health services across most of the country.
The ruling casts doubt on statements from the federal health secretary, Robert F. Kennedy Jr., who speculated that measles deaths reported by the state may have been “fabricated.”
The KwaZulu-Natal government has launched a R148 million project to build the Ilembe district's first dedicated public psychiatric hospital, ending years of patient transfers.
Kenya’s push to tighten pharmacy standards is exposing a difficult question for the health system: can the country raise professional requirements without creating staffing gaps that make medicines…
